Showing results (191-200 of 204) with videos related to
Sort By:
Pageof 21
Cell|April 28, 2022
Enhanced safety and efficacy of protease-regulated CAR-T cell receptorsLouai Labanieh, Robbie G Majzner, Dorota Klysz, et al.Proceedings of the National Academy of Sciences of the United States of America|March 18, 2009
Antibodies specifically targeting a locally misfolded region of tumor associated EGFRThomas P J Garrett, Antony W Burgess, Hui K Gan, et al.Nature Communications|May 19, 2022
Broad-spectrum CRISPR-mediated inhibition of SARS-CoV-2 variants and endemic coronaviruses in vitroLeiping Zeng, Yanxia Liu, Xammy Huu Nguyenla, et al.Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild IllnessKatharina Röltgen, Oliver F Wirz, Bryan A Stevens, et al.Science Immunology|December 8, 2020
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcomeKatharina Röltgen, Abigail E Powell, Oliver F Wirz, et al.Nature Biotechnology|May 1, 2023
A highly efficient transgene knock-in technology in clinically relevant cell typesAlexander G Allen, Samia Q Khan, Carrie M Margulies, et al.Neuro-Oncology|May 29, 2021
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastomaBianca-Maria Marin, Kendra A Porath, Sonia Jain, et al.Cancer Cell|January 23, 2026
IGSF11-VISTA is a critical and targetable immune checkpoint axis in diffuse midline gliomaRaphaël Collot, Cristian Ruiz-Moreno, Celina Honhoff, et al.Cell Stem Cell|May 14, 2019
YAP, but Not RSPO-LGR4/5, Signaling in Biliary Epithelial Cells Promotes a Ductular Reaction in Response to Liver InjuryLara Planas-Paz, Tianliang Sun, Monika Pikiolek, et al.Nature|May 15, 2024
Engineered CD47 protects T cells for enhanced antitumour immunitySean A Yamada-Hunter, Johanna Theruvath, Brianna J McIntosh, et al.Pageof 21